Stay tuned for our monthly news!

Stay informed

No, thanks

Insights

For a better healthcare. Part 4: Who owns the case

A continuous-care layer is the obvious fix. It is also the most dangerous one, because done carelessly it builds the very two-tier system it was meant to prevent. This final piece is about doing it carefully.

Pedro Stark
By Pedro Stark
7 min read

About the author

Pedro Stark

Pedro Stark

Group Managing Partner

We have arrived at the part everyone wants to skip to.

Part 1 argued that the core problem is that nobody owns the patient's case from beginning to end. Part 2 showed that coordination only works when someone is genuinely accountable for the result and paid for resolving it, rather than for activity. Part 3 showed that the money to pay for all of this is already in the system, lost inside avoidable admissions and patients treated in the wrong, expensive place.

So the diagnosis is complete, and frankly not very controversial. What remains is the only hard question left: who owns the layer, who pays for it, and how we build it without making things worse.

That last clause matters more than the other two, so let me start there.

The trap

The intuitive solution is a dedicated team that takes a patient's case and carries it. It maps the path, books the specialists, chases the results, and closes the loop. Call it continuous care, care navigation, a concierge layer. The name is not the point.

The danger is.

Across Europe a quiet two-tier system is already forming, not by design but by exhaustion. Where the public queue grows too long, the people who can afford it pay to step out of it. This is not a hypothesis. In Portugal, a Católica Lisbon study in July 2025 found that 89.6% of people believe the public service is deteriorating, and eight in ten worry they will have to pay more for their care. They are right to worry. Separate research from Nova School of Business and Economics found that the share of Portuguese relying exclusively on the public system fell from 90% in 2022 to 82% in 2025, and that by 2025 around 15% had taken on a private family doctor. The exit is already happening, and it is measurable.

Now imagine bolting a polished, well-run continuous-care layer on top of that, and charging for access to it. You would not have solved the two-tier problem. You would have productised it.

A coordination layer you buy your way into is not a reform. It is the exit valve with better branding.

This is the failure mode that most enthusiastic talk about continuous care tends to glide past. It is also the one that would discredit the whole idea fastest.

The four conditions that avoid it

If the layer is going to sit inside public healthcare rather than feed on it, four things have to be true. Not preferences. Structural conditions.

  • Publicly funded, from recovered waste. The layer is paid for out of the misrouting savings from Part 3, not out of the patient's pocket. The test is blunt: if a patient is ever asked to pay for coordination, the model has already failed.
  • Allocated by need, not by means. The people who benefit most are the multimorbid minority who drive the bulk of the cost and almost all of the chaos. They get the layer because their case is complex, not because they can afford it.
  • Accountable on outcomes. Whoever runs the layer is paid for resolved cases and shared savings, in the Kinzigtal mould, not for headcount or throughput. The incentive has to point at the patient getting better, faster, and cheaper.
  • Clinically subordinate to the public system. The doctors and the clinical authority stay public. The layer owns the route, not the medicine. It coordinates care; it does not commission or overrule it.

Get those four right and the layer is a public good that happens to be run efficiently. Get even one of them wrong and you are building a fast lane for the wealthy.

The cherry-picking objection

There is an obvious objection to all this. Pay a private operator for resolved cases and shared savings, and will it not simply take the easy patients and quietly avoid the hard ones?

It is the right worry, and the design has to answer it head on. Two things do.

First, who gets referred is decided by the public system on clinical need, not by the operator on commercial appeal. The patients the layer exists for are, by definition, the complicated and expensive ones. Second, an outcomes contract that pays for closed cases and shared savings across a defined population, the Kinzigtal structure again, pays precisely for resolving difficulty, not for skimming simplicity. Get the contract right and cherry-picking stops being profitable.

What it looks like for one patient

Return to the woman from Part 2, with diabetes, heart failure and a hip that needs replacing.

Under this design she enters the layer not because she can pay, but because her case is complex. A named team takes ownership of it. They sequence the three specialties so the hip surgery is not derailed by unmanaged blood sugar. They hold the record, so she stops being the courier of her own history. And they are paid when her case is closed and the expensive emergency admission that would otherwise have come is avoided.

Nothing in that requires her to reach for her wallet. That is the whole point.

Public or private is the wrong question

Notice what the four conditions do not say. They do not say the layer must be run by a government department.

The argument over whether such a layer is "public" or "private" is mostly a distraction. What matters is who carries the accountability and who funds the access. A privately operated team working under a public outcomes contract, paid from public savings, serving patients by clinical need, is public where it counts and private only in its operating discipline. A state-run layer that quietly serves the articulate and well-connected first is private where it counts, whatever the letterhead says.

The test is not who runs it. The test is who can get it, and who pays.

Why now

There is a reason this is a 2026 conversation and not a 2016 one.

The European Union has begun funding precisely this, and the name it chose is telling. The 2026 to 2027 Horizon Europe health programme has a funding destination called, in plain words, "ensuring equal access to innovative, sustainable, and high-quality healthcare." Its lead call funds the public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches, with a first deadline in April 2026. A second call in the same destination goes after low-value care, the waste from Part 3.

The mechanism matters as much as the money. Procurement of innovative solutions means the public system is the buyer and the early adopter, opening a market for providers while the access itself stays public. The patient is not the customer. The system is. That single distinction is what separates a public good from a private fast lane, and the EU has, for once, put its funding behind the right side of it.

Where this leaves us

The series began by arguing that European public healthcare is not failing on medicine. It is failing on ownership. Nobody holds the patient's case end to end, and every downstream symptom, the queues, the waste, the drift to private care, follows from that single gap.

The fix is not heroic. It is a layer that owns the case, funded by the waste it removes, allocated by need, accountable on outcomes, and answerable clinically to the public system. None of that demands a new theory of medicine. It demands a decision about who is responsible.

The diagnosis was always the easy part. The design is where this is won or lost. The systems that get the design right will not merely shorten their queues. They will rebuild the foundation the first piece described, the one a universal system was always supposed to stand on.

That is the work. It is available now. The only missing ingredient is the decision to own it.


Sources

  1. Observatory of Portuguese Society, Behavioral Insights Unit, Católica Lisbon School of Business and Economics (2025), Current Concerns of Portuguese Society: Housing, Levels of Emigration and Immigration, and Health(fieldwork 10 to 18 July 2025, n = 1,134). clsbe.lisboa.ucp.pt. On 89.6% perceiving SNS decline and the share worried about paying more.
  2. Nova School of Business and Economics, healthcare access survey, reported January 2026. On exclusive use of the public system falling from 90% to 82% between 2022 and 2025, and the rise in private family doctors.
  3. European Commission (2025), Horizon Europe Work Programme 2026-2027, Cluster 1: Health, Destination "Ensuring equal access to innovative, sustainable, and high-quality healthcare," call HORIZON-HLTH-2026-01-CARE-01. hadea.ec.europa.eu. On the public procurement of integrated-care solutions.
  4. Hildebrandt H. et al. (2010), "Gesundes Kinzigtal Integrated Care: improving population health by a shared health gain approach and a shared savings contract," International Journal of Integrated Care. On the outcomes-based, shared-savings contract model.

Part 4 of a four-part series on rebuilding the operating model of European public healthcare. Thank you for reading.

We use cookies to give you the best possible experience, and while some are essential, others help us understand how you use the site, so we can improve it. Click “Accept all cookies” to proceed as specified, “Decline optional cookies” to accept only essential cookies, or click “Manage my preferences” to choose what cookie types you will accept. Cookie Policy.

© CW1 Inc, All rights reserved
CW1 Group